Uncategorized

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced the pricing of an underwritten public offering of 17,500,000 ordinary shares and accompanying warrants to purchase 17,500,000 ordinary shares at a public offering price of $1.30 per ordinary share.

Direct Biologics Reports Compelling Data as ExoFlo ™ Expanded Access Program in Hospitalized COVID-19 Patients with Moderate-to-Severe ARDS Surpasses 100 Subjects.

Nano Labs Ltd announced today that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2022, with the U.S. Securities and Exchange Commission (“SEC”) on April 18, 2023.

MacuHealth, the leader in innovative eye supplements, is introducing LifeMeter, a portable, non-invasive device proven to measure the presence of vital antioxidants known as carotenoids.

Noticias de la actualidad científica y tecnológica del 14 de abril de 2023.     …

Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.

Zucara Therapeutics Inc., today announced that the U.S. Food and Drug Administration (“FDA”) has cleared the Company’s Investigational New Drug (“IND”) application for ZT-01 for the prevention of night-time (nocturnal) hypoglycemia in patients with Type 1 Diabetes (“T1D”).

Palatin Technologies today announced preliminary fiscal third quarter ended March 31, 2023 Vyleesi® product revenue results.

Annovis Bio, Inc. today announced that patient recruitment for the Company’s Phase 2/3 study of buntanetap for the treatment of moderate Alzheimer’s disease (AD) remains consistent with its planned development program.

Hay un agujero negro que, pese a su enorme masa de 20 millones de veces la de nuestro Sol, avanza por el espacio intergaláctico muchísimo más rápido que la más veloz de nuestras naves espaciales. A esa velocidad, este astro tan masivo podría viajar de la Tie …